Cellectis (CLLS) EBT Margin (2015 - 2026)
Cellectis (CLLS) posted EBT Margin of 358.72% for Q1 2026, up 57.79% on a QoQ basis from 849.91% in Q4 2025, and down 32180.0% year-over-year from N/an in Q1 2025.
Cellectis (CLLS) has 12 years of EBT Margin data on file, last reported at 358.72% in Q1 2026.
- In Q1 2026, EBT Margin fell 32180.0% year-over-year to 358.72%; the TTM figure through Mar 2026 stood at 141.69% (down 4014.0% YoY), while the FY2025 annual figure was 93.24%, down 1855.0% from the prior year.
- EBT Margin climbed to 358.72% in Q1 2026, from 849.91% in the prior quarter.
- Across five years, EBT Margin topped out at 1743.26% in Q2 2023 and bottomed at 31081.27% in Q4 2023.
- A 5-year average of 4236.69% and a median of 358.72% in 2026 frame the typical range for EBT Margin.
- Annual changes were most pronounced in 2023 — EBT Margin sank 3106321 bps — and 2024, when it jumped 3080546 bps.
- Year by year, EBT Margin stood at 18.06% in 2022, then plunged by 171970 bps to 31081.27% in 2023, then soared by 99 bps to 275.81% in 2024, then plunged by 208 bps to 849.91% in 2025, then soared by 58 bps to 358.72% in 2026.
- The last three EBT Margin figures came in at 358.72% (Q1 2026), 849.91% (Q4 2025), and 53.89% (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | -6.40% |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 41.95% |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 23.05% |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 18.99% |
| 10 | Cellectis | 20.83 Bn | 20.62 Bn | - | -358.72% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -358.72% |
| Dec 31, 2025 | -849.91% |
| Sep 30, 2025 | 53.89% |
| Jun 30, 2025 | 60.44% |
| Mar 31, 2025 | -36.91% |
| Dec 31, 2024 | -275.81% |
| Sep 30, 2024 | 28.64% |
| Jun 30, 2024 | -7.01% |
| Mar 31, 2024 | -392.18% |
| Dec 31, 2023 | -31,081.27% |
| Sep 30, 2023 | -9,114.84% |
| Jun 30, 2023 | 1,743.26% |
| Mar 31, 2023 | -13,132.37% |
| Dec 31, 2022 | -18.06% |
| Sep 30, 2022 | -15,008.57% |
| Jun 30, 2022 | -1,960.37% |
| Mar 31, 2022 | -1,673.87% |
| Dec 31, 2021 | -78.67% |
| Sep 30, 2021 | -509.72% |
| Jun 30, 2021 | -335.37% |
| Mar 31, 2021 | -77.76% |
| Dec 31, 2020 | -286.94% |
| Sep 30, 2020 | -475.04% |
| Jun 30, 2020 | -1,139.00% |
| Mar 31, 2020 | 28.75% |
| Dec 31, 2019 | -870.34% |
| Sep 30, 2019 | -314.02% |
| Jun 30, 2019 | -3,049.13% |
| Mar 31, 2019 | -2,231.56% |
| Dec 31, 2018 | -3,023.24% |
| Sep 30, 2018 | -3,190.29% |
| Jun 30, 2018 | -429.71% |
| Mar 31, 2018 | -412.28% |
| Dec 31, 2017 | -401.77% |
| Sep 30, 2017 | -419.85% |
| Jun 30, 2017 | -305.45% |
| Mar 31, 2017 | -293.25% |
| Dec 31, 2016 | -247.87% |
| Sep 30, 2016 | -114.48% |
| Jun 30, 2016 | -1,678.06% |
| Mar 31, 2016 | -292.48% |
| Dec 31, 2015 | 3.65% |
| Sep 30, 2015 | -176.93% |
| Jun 30, 2015 | -165.47% |
| Mar 31, 2015 | -42.22% |